ACHIEVE Investigator Development Core
ACHIEVE 研究者开发核心
基本信息
- 批准号:10494189
- 负责人:
- 金额:$ 81.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract
The overarching goal of the Investigator Development Core (IDC) is to create a climate where
collaborative and innovative research can thrive, leading to improved population health through sound
research and implementation science. The IDC will provide opportunities for a diverse cohort of highly
skilled early-stage investigators (ESI) to develop and pilot innovative research studies by efficiently
leveraging existing resources across three major research institutions in the proposed ACHIEVE
GREATER. The IDC will provide training and consultation on study design and biostatistics, provide a
seed funding program, and facilitate access to key infrastructure including banked biospecimens and
electronic health records, and an array of data located in the newly developed Wayne State
University (WSU) Google-Cloud-based data warehouse, ingestion, and dissemination platform. The
core function of the IDC is to promote the research careers of the pilot project awardees to become
highly competitive applicants for competitive extramural support. The IDC will specifically encourage
early-stage investigators from different disciplines and backgrounds to focus on chronic disease
disparities to enhance workforce diversity. The specific aims of the IDC are to plan each year's
funding opportunity with input from our community advisors and ACHIEVE GREATER program
leaders. This program will be available to the ACHIEVE GREATER membership and broader Wayne
State University (WSU), Henry Ford Health System (HFHS) and Case Western Reserve University
(CWRU)/University Hospitals (UH) research communities. Interested applicants will submit a letter of
intent (LOI) which will be reviewed by the Scientific Advisory Committee ( SAC). Applicants with
highly meritorious LOIs will be invited to submit a full application and will receive assistance from the
administrative core on biostatistics, study design, IRB and other regulatory matters. The IDC will
award six new pilot project grants each year of the 5-year ACHIEVE GREATER funding cycle with
each award including funds of $40,000 over a 1-year period. In addition, we will provide awardees
with programmatic support, which includes IRB as well as statistical support at no cost to them. The
IDC Director (Dr. Safwan Badr – WSU) and Assistant Director (Dr. Sadeer Al-Kindi – CWRU) will
oversee an advisory team that meets regularly with ACHIEVE GREATER pilot project recipients to
review progress and provide guidance. Finally, we will track success measures including publications
and competitive extramural awards. Overall, the IDC will nurture and support transformational
research on chronic disease prevention with favorable impact on population health.
摘要
研究者发展核心(IDC)的总体目标是创造一种氛围,
合作和创新研究可以蓬勃发展,通过健全的健康,
研究和实施科学。IDC将为高度多样化的群体提供机会,
熟练的早期研究人员(ESI)通过有效地开发和试点创新研究
在拟议的ACHIEVE中利用三个主要研究机构的现有资源
更大IDC将提供研究设计和生物统计学方面的培训和咨询,
种子资金计划,并促进获得关键基础设施,包括库存生物标本,
电子健康记录和位于新开发的韦恩州的一系列数据
大学(WSU)基于Google云的数据仓库,摄取和传播平台。的
IDC的核心职能是促进试点项目获奖者的研究事业,
非常有竞争力的申请人竞争激烈的校外支持。IDC将特别鼓励
来自不同学科和背景的早期研究人员专注于慢性病
提高劳动力的多样性。IDC的具体目标是规划每年的
通过我们的社区顾问和ACHIEVE GREATER计划的投入获得资助机会
领导人的人选信号该计划将提供给ACHIEVE GREATER会员和更广泛的韦恩
州立大学(WSU)、亨利福特卫生系统(HFHS)和凯斯西储大学
(CWRU)/大学医院(UH)研究社区。有兴趣的申请人将提交一封信,
意向书(LOI)将由科学咨询委员会(SAC)审查。的申请人
非常优秀的意向书将被邀请提交一份完整的申请,并将获得
生物统计学、研究设计、IRB和其他监管事务的行政核心。IDC将
在为期5年的“成就更大”资助周期中,每年提供6笔新的试点项目赠款,
每项奖励包括为期一年的40 000美元资金。此外,我们将为获奖者提供
方案支助,包括IRB以及统计支助,不收取任何费用。的
IDC主任(Safwan Badr博士- WSU)和助理主任(Sadeer Al-Kindi博士- CWRU)将
监督一个咨询小组,该小组定期与ACHIEVE GREATER试点项目接受者会面,
审查进展并提供指导。最后,我们将跟踪包括出版物在内的成功措施
和竞争激烈的校外奖项。总体而言,IDC将培育和支持转型
开展对人群健康有利的慢性病预防研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Safwan Badr其他文献
M. Safwan Badr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Safwan Badr', 18)}}的其他基金
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
中枢性睡眠呼吸暂停:指导治疗的生理机制
- 批准号:
10578689 - 财政年份:2020
- 资助金额:
$ 81.69万 - 项目类别:
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
中枢性睡眠呼吸暂停:指导治疗的生理机制
- 批准号:
10390291 - 财政年份:2020
- 资助金额:
$ 81.69万 - 项目类别:
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
中枢性睡眠呼吸暂停:指导治疗的生理机制
- 批准号:
9889338 - 财政年份:2020
- 资助金额:
$ 81.69万 - 项目类别:
Improving outcomes for patients with SDB and insufficient sleep
改善 SDB 和睡眠不足患者的预后
- 批准号:
10488651 - 财政年份:2019
- 资助金额:
$ 81.69万 - 项目类别:
Improving outcomes for patients with SDB and insufficient sleep
改善 SDB 和睡眠不足患者的预后
- 批准号:
10689812 - 财政年份:2019
- 资助金额:
$ 81.69万 - 项目类别:
Improving outcomes for patients with SDB and insufficient sleep
改善 SDB 和睡眠不足患者的预后
- 批准号:
10241257 - 财政年份:2019
- 资助金额:
$ 81.69万 - 项目类别:
Sleep-Disordered Breathing in patients with C-SCI: Mechanisms and Therapy
C-SCI 患者的睡眠呼吸障碍:机制和治疗
- 批准号:
9331700 - 财政年份:2016
- 资助金额:
$ 81.69万 - 项目类别:
Sleep and Breathing in Patients With Spinal Cord Injury
脊髓损伤患者的睡眠和呼吸
- 批准号:
8967213 - 财政年份:2014
- 资助金额:
$ 81.69万 - 项目类别:
相似国自然基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
- 批准号:32070202
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
- 批准号:
- 批准年份:2020
- 资助金额:40 万元
- 项目类别:
相似海外基金
Development of a new solid tritium breeder blanket
新型固体氚增殖毯的研制
- 批准号:
2908923 - 财政年份:2027
- 资助金额:
$ 81.69万 - 项目类别:
Studentship
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
- 批准号:
2734768 - 财政年份:2026
- 资助金额:
$ 81.69万 - 项目类别:
Studentship
REU Site: Microbial Biofilm Development, Resistance, & Community Structure
REU 网站:微生物生物膜的发展、耐药性、
- 批准号:
2349311 - 财政年份:2025
- 资助金额:
$ 81.69万 - 项目类别:
Continuing Grant
SoundDecisions - Musical Listening, Decision Making, And Equitable Development In The Mekong Delta
SoundDecisions - 湄公河三角洲的音乐聆听、决策和公平发展
- 批准号:
EP/Z000424/1 - 财政年份:2025
- 资助金额:
$ 81.69万 - 项目类别:
Research Grant
Bio-MATSUPER: Development of high-performance supercapacitors based on bio-based carbon materials
Bio-MATSUPER:开发基于生物基碳材料的高性能超级电容器
- 批准号:
EP/Z001013/1 - 财政年份:2025
- 资助金额:
$ 81.69万 - 项目类别:
Fellowship
Development of a Cell-Based Assay for Tetanus Vaccine Quality Control
破伤风疫苗质量控制细胞检测方法的开发
- 批准号:
10101986 - 财政年份:2024
- 资助金额:
$ 81.69万 - 项目类别:
Collaborative R&D
HURR — Platform Development
HURR – 平台开发
- 批准号:
10103254 - 财政年份:2024
- 资助金额:
$ 81.69万 - 项目类别:
Investment Accelerator
Automatic battery swapping cabinet development for scalability of e-mobility in Uganda
自动电池交换柜开发,以提高乌干达电动汽车的可扩展性
- 批准号:
10080435 - 财政年份:2024
- 资助金额:
$ 81.69万 - 项目类别:
Collaborative R&D
Development of digital diagnostics services for Parkinson’s disease
开发帕金森病数字诊断服务
- 批准号:
10086932 - 财政年份:2024
- 资助金额:
$ 81.69万 - 项目类别:
Collaborative R&D
RestoreDNA: Development of scalable eDNA-based solutions for biodiversity regulators and nature-related disclosure
RestoreDNA:为生物多样性监管机构和自然相关披露开发可扩展的基于 eDNA 的解决方案
- 批准号:
10086990 - 财政年份:2024
- 资助金额:
$ 81.69万 - 项目类别:
Collaborative R&D














{{item.name}}会员




